Valuing prevention: lessons and recommendations from a Dutch expert committee
Expert Review of Pharmacoeconomics & Outcomes Research · 2025
DOI: 10.1080/14737167.2025.2504946 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2025. Verfasst von Adriënne Rotteveel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Public Health, Healthcare and Society, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. Hauptthemen laut MEDLINE: Delivery of Health Care, Preventive Health Services. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
INTRODUCTION: Countries have been struggling with investments in prevention. How to obtain insight in the costs, benefits, and budgetary impacts of investments in prevention? And how to weigh investments in prevention against other investments in health, such as in curative health care. In the Netherlands, in 2023, a methodological expert committee was established to answer such questions. Their advice, published in January 2024, has been impactful, receiving much attention in Dutch politics and policy and leading to the establishment of a subsequent scientific committee on appropriate evidence and the development of an investment model for prevention. AREAS COVERED: In this perspective, we present the main recommendations from the advice and embed these recommendations in the Dutch institutional context. Furthermore, we highlight why the financing of prevention is challenging and suggest some solutions. Finally, we discuss how the advice was received and what follow-up was given, reflect on why this advice had such a large impact, and distill recommendations for other countries from this experience. EXPERT OPINION: Economic evaluation of prevention is not intrinsically more challenging than that of other health investments. For a direct comparison of investments in health, similar methods should be used for both prevention and medical care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Public Health, Healthcare and Society, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
- Research, Development & Medicines, National Health Care Institute, Diemen, The Netherlands.
- Faculty of Science, Department of Health Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Department Tranzo, Tilburg University, TSB, Tilburg, The Netherlands.
- IQ Health, Radboud University Medical Center, The Netherlands.
Zitieren
APA
Rotteveel, A., Knies, S., de Wit, A., Polder, J., & Wouterse, B. (2025). Valuing prevention: lessons and recommendations from a Dutch expert committee. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2025.2504946
Vancouver
Rotteveel A, Knies S, de Wit A, Polder J, Wouterse B. Valuing prevention: lessons and recommendations from a Dutch expert committee. Expert Review of Pharmacoeconomics & Outcomes Research. 2025. doi:10.1080/14737167.2025.2504946
BibTeX
@article{Rotteveel2025,
author = {Rotteveel, Adriënne and Knies, Saskia and de Wit, Ardine and Polder, Johan and Wouterse, Bram},
title = {Valuing prevention: lessons and recommendations from a Dutch expert committee},
journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
year = {2025},
doi = {10.1080/14737167.2025.2504946}
}
EUVIMED